Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative esketamine for severe burn patients undergoing surgery
ChiCTR2000034069Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine in burn injury (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Subjective analgesic efficacy. Started Sep 2020; status: recruiting.
02
Drugs
esketamine
03
Conditions
burn injury
Beyond the preview
Go deeper on ChiCTR2000034069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034069.